gener
new
liveattenu
vaccin
ebola
viru
ebov
base
chimer
viru
contain
ebov
glycoprotein
gp
sole
transmembran
envelop
protein
combin
intern
protein
human
parainfluenza
viru
type
electron
microscopi
analysi
viru
particl
show
envelop
surfac
spike
resembl
ebov
particl
size
shape
resembl
inocul
via
apic
surfac
vitro
model
human
ciliat
airway
epithelium
viru
releas
apic
surfac
appli
basolater
surfac
viru
infect
basolater
cell
spread
tissu
follow
intranas
inocul
guinea
pig
scatter
infect
cell
detect
lung
immunohistochemistri
infecti
could
recov
lung
blood
tissu
despit
attenu
viru
highli
immunogen
singl
dose
complet
protect
anim
highli
lethal
intraperiton
challeng
guinea
pigadapt
ebov
ebola
viru
ebov
along
close
relat
marburg
viru
belong
famili
filovirida
caus
sporad
outbreak
hemorrhag
fever
central
africa
mortal
rate
review
sanchez
geisbert
feldmann
multipl
initi
attempt
develop
vaccin
ebov
unsuccess
suggest
protect
immun
ebov
easili
achiev
past
decad
howev
vector
approach
develop
vaccin
ebov
use
adenovirus
vesicular
stomat
viru
vsv
human
parainfluenza
type
venezuelan
equin
enceph
viru
replicon
result
dramat
advanc
vaccin
develop
nonetheless
approv
vaccin
ebov
exist
far
review
collin
bukreyev
ebov
transmit
contact
infect
fluid
tissu
mucos
membran
break
skin
geisbert
jahrl
jaax
et
al
jaax
et
al
addit
infect
demonstr
nonhuman
primat
aerosol
administr
viru
thu
develop
vaccin
induc
strong
local
immun
respons
respiratori
tract
addit
system
immun
would
advantag
previous
develop
topic
respiratori
tract
vaccin
ebov
base
human
parainfluenza
viru
type
common
pediatr
respiratori
pathogen
review
karron
collin
involv
modifi
complet
infecti
ad
addit
transcript
cassett
express
ebov
gp
result
viru
effici
infect
guinea
pig
nonhuman
primat
induc
strong
system
local
immun
respons
respiratori
tract
confer
high
level
protect
intraperiton
ip
challeng
ebov
bukreyev
et
al
howev
evalu
variou
human
adenoviru
type
vaccinia
virusvector
vaccin
casimiro
et
al
fitzgerald
et
al
kanesathasan
et
al
lemckert
et
al
sharp
et
al
sumida
et
al
zhi
et
al
includ
adenovirusvector
vaccin
ebov
yang
et
al
anim
model
clinic
studi
demonstr
preexist
immun
vector
abolish
greatli
reduc
immunogen
express
foreign
antigen
also
potenti
concern
vaccin
given
high
seropreval
due
natur
exposur
concern
somewhat
amelior
recent
observ
replic
inde
strongli
restrict
guinea
pig
previous
infect
immunogen
ebov
gp
insert
greatli
affect
yang
et
al
howev
unusu
studi
small
experiment
anim
provid
overli
optimist
vaccin
efficaci
data
result
remain
confirm
nonhuman
primat
model
geisbert
et
al
thu
would
use
modifi
vector
reduc
sensit
restrict
preexist
immun
gp
sole
ebov
transmembran
envelop
surfac
protein
mediat
attach
cellular
receptor
fusion
viral
envelop
cellular
plasma
membran
sanchez
geisbert
feldmann
contrast
two
transmembran
envelop
surfac
protein
hemagglutininneuraminidas
hn
mediat
receptor
attach
fusion
protein
f
respons
membran
fusion
collin
crow
sinc
hn
f
sole
neutral
antigen
explor
possibl
develop
chimer
viru
lack
hn
f
instead
contain
ebov
gp
sole
surfac
protein
combin
intern
protein
present
studi
report
success
recoveri
chimer
viru
ebogp
character
viral
particl
electron
microscopi
confirm
constel
virion
protein
express
infect
cell
test
abil
viru
grow
variou
cell
line
determin
effect
neutral
antibodi
growth
vitro
test
effect
gp
polar
vector
infect
human
ciliat
airway
epithelium
hae
final
use
guinea
pig
model
determin
extent
viru
replic
organ
distribut
immunogen
protect
efficaci
vaccin
viru
ebov
challeng
vivo
previous
construct
fig
complet
recombin
modifi
insert
p
gene
code
sequenc
ebov
gp
flank
genestart
gs
geneend
ge
transcript
signal
bukreyev
et
al
present
studi
modifi
delet
f
hn
gene
creat
fig
b
encod
full
length
ebov
gp
sanchez
et
al
volchkov
et
al
sole
viral
surfac
protein
thu
infect
chimer
viru
would
depend
incorpor
ebov
gp
direct
attach
fusion
particl
ebov
gp
type
transmembran
protein
unusu
short
ctermin
cytoplasm
tail
ct
kfvf
sanchez
et
al
bear
sequenc
similar
much
longer
amino
acid
ctermin
ct
type
f
protein
sprigg
et
al
amino
acid
ntermin
ct
type
ii
hn
protein
elango
et
al
effici
incorpor
foreign
glycoprotein
viru
particl
influenc
ct
replac
foreign
ct
endogen
glycoprotein
increas
incorpor
tao
et
al
therefor
also
design
second
viru
ct
ebov
gp
replac
f
protein
fig
c
new
chimer
construct
conform
rule
six
ie
genom
length
even
multipl
six
nucleotid
design
hexam
space
transcript
signal
conserv
ie
first
last
gene
n
l
initi
second
hexam
nucleotid
gene
initi
first
hexam
nucleotid
kolakofski
et
al
viru
express
complet
ebov
gp
readili
recover
viabl
contrast
viru
express
gp
modifi
ct
f
recover
multipl
experi
evidenc
cluster
round
cell
could
amplifi
suffici
use
experi
consid
recov
amplifi
viru
region
modifi
well
entir
ebov
gp
amplifi
rtpcr
analyz
sequenc
confirm
expect
sequenc
demonstr
lack
adventiti
mutat
region
purifi
ultracentrifug
sucros
step
gradient
compar
morpholog
viru
particl
electron
microscopi
versu
ebov
fig
show
overal
size
shape
particl
similar
howev
envelop
resembl
ebov
regard
appear
surfac
spike
sanchez
geisbert
feldmann
approxim
thinner
gradientpurifi
particl
also
analyz
gel
electrophoresi
reduc
denatur
condit
follow
silver
stain
fig
western
blot
analysi
antiserum
ebov
gp
fig
silverstain
gel
pattern
gradientpurifi
particl
fig
lane
lack
hn
protein
expect
wherea
speci
evid
prepar
lane
respect
note
band
much
less
visibl
locat
close
unidentifi
abund
band
analysi
silver
stain
fig
western
blot
fig
also
reveal
presenc
ebov
gp
migrat
slightli
kda
marker
band
prepar
lane
lane
vector
lane
importantli
assay
gp
band
substanti
denser
prepar
densitomet
analysi
silver
stain
gel
show
gp
n
ratio
compar
nearli
twofold
greater
incorpor
gp
like
attribut
absenc
hn
f
envelop
protein
first
compar
plaqu
size
ebogp
monkey
kidney
cell
infect
serial
dilut
three
virus
cover
medium
contain
methylcellulos
incub
day
plaqu
visual
immunostain
antibodi
rais
purifi
case
antibodi
rais
purifi
inactiv
ebov
case
plaqu
smaller
averag
diamet
plaqu
fig
suggest
attenu
construct
averag
diamet
plaqu
form
plaqu
similar
result
obtain
vero
cell
shown
unexpectedli
found
form
plaqu
readili
cell
tcid
found
equival
pfu
wherea
tcid
equival
pfu
suggest
differ
effici
plaqu
format
comparison
tcid
ebogp
equal
pfu
thu
close
resembl
thu
replac
f
hn
protein
ebov
gp
dramat
enhanc
abil
viru
form
plaqu
although
plaqu
reduc
size
compar
ebogp
mechanist
basi
effect
unknown
experi
report
titer
inocula
base
pfu
amount
less
rel
respect
titer
inocula
base
tcid
provid
conserv
evalu
perform
viru
compar
growth
kinet
monolay
cultur
vero
monkey
kidney
cell
human
respiratori
epitheli
cell
follow
infect
input
moi
pfucel
fig
cell
growth
delay
compar
virus
increas
steadili
day
titer
high
log
pfuml
similar
vero
cell
growth
indistinguish
achiev
titer
excess
log
pfuml
wherea
achiev
titer
higher
condit
effici
replic
vero
cell
import
approv
substrat
manufactur
vaccin
human
use
contrast
human
cell
sever
attenu
compar
virus
titer
never
exceed
log
pfuml
next
evalu
infect
vitro
model
human
airway
epithelium
hae
model
consist
primari
cell
clinic
specimen
grown
differenti
vitro
polar
pseudostratifi
ciliat
epithelium
morpholog
function
similar
epithelium
conduct
airway
hae
prepar
multipl
donor
inocul
moi
pfucel
via
apic
basolater
surfac
note
due
structur
particular
cultur
support
inocul
basolater
surfac
also
expos
apic
surfac
viru
day
post
inocul
cultur
fix
viral
antigen
detect
histolog
crosssect
use
antibodi
virion
prepar
fig
b
c
ebov
fig
e
follow
apic
inocul
fig
left
side
mostli
ciliat
epitheli
cell
posit
viru
antigen
consist
previou
find
zhang
et
al
loss
cilia
andor
ciliat
cell
note
day
postinocul
apic
inocul
fig
left
side
also
result
infect
ciliat
cell
although
reduc
number
base
analysi
multipl
hae
mean
percentag
se
infect
ciliat
cell
follow
apic
inocul
follow
base
prepar
base
prepar
p
contrast
apic
infect
result
rare
isol
infect
cell
apic
layer
visibl
destruct
cell
cilia
fig
left
side
basolater
inocul
expos
surfac
viru
detect
infect
basolater
cell
although
numer
ciliat
cell
apic
surfac
infect
fig
right
side
basolater
inocul
fig
right
side
show
pattern
except
noncili
nonap
cell
eg
basal
cell
also
occasion
infect
shown
suggest
ebov
gp
may
increas
tropism
basal
noncili
celltyp
basolater
infect
fig
right
side
occasion
infect
individu
cluster
cell
detect
locat
apic
basolater
intermedi
cell
layer
start
day
data
indic
three
virus
infect
apic
cell
hae
order
effici
express
ebov
gp
confer
abil
infect
basolater
intermedi
layer
hae
howev
infect
via
apic
surfac
never
penetr
beyond
superfici
cell
littl
antigen
detect
cilia
infect
cell
use
particular
polyval
antiserum
although
previou
studi
use
monoclon
antibodi
specif
f
protein
express
observ
cilia
zhang
et
al
differ
like
consequ
use
differ
antibodi
prepar
two
studi
interestingli
present
studi
cilia
also
strongli
stain
antiebov
antibodi
sinc
gp
ebov
antigen
express
ebogp
specif
identifi
ebov
gp
signific
region
distribut
gp
regard
viral
assembl
bud
remain
determin
separ
experi
triplic
hae
cultur
per
viru
inocul
via
apic
basolater
surfac
latter
expos
surfac
kinet
viral
growth
hae
determin
fig
experi
demonstr
follow
apic
inocul
three
virus
detect
apic
compart
time
point
test
although
somewhat
attenu
compar
even
attenu
differ
gener
consist
number
virusposit
cell
observ
day
experi
shown
fig
contrast
viru
detect
basolater
side
follow
apic
inocul
shown
inocul
basolater
rout
sampl
collect
apic
surfac
titer
rapidli
increas
high
titer
day
indic
robust
viral
replic
shed
apic
surfac
wherea
replic
shed
bare
detect
titer
presum
reflect
exposur
apic
cell
virus
basolater
collect
intermedi
viral
titer
log
pfuml
detect
three
virus
day
littl
viru
later
time
point
note
sever
aspect
specif
inocul
basolater
surfac
probabl
enhanc
retent
initi
inoculum
surfac
name
basal
cell
tightli
coupl
polytetrafluoroethylen
support
underli
basal
surfac
like
reduc
effici
wash
singl
wash
perform
thu
titer
day
like
reflect
residu
inoculum
rather
de
novo
viru
replic
taken
togeth
data
suggest
presenc
ebov
gp
sole
envelop
protein
virion
result
limit
infect
apic
basolater
surfac
hae
shed
detect
apic
surfac
basolater
surfac
determin
suscept
antibodi
combin
optimem
contain
pfu
guinea
pig
complement
optimem
contain
dilut
serum
rabbit
hyperimmun
purifi
prepar
neg
control
contain
complement
serum
mixtur
incub
h
residu
infect
determin
plaqu
titrat
titer
infecti
determin
sampl
contain
lack
serum
pfu
residu
infect
detect
pfu
respect
indic
complet
neutral
antibodi
expect
wherea
control
approxim
reduct
might
reflect
nonspecif
effect
incub
presenc
complement
contrast
titer
sampl
contain
lack
serum
pfu
pfu
respect
indic
lack
sensit
viru
antibodi
also
confirm
multicycl
growth
cell
cultur
shown
inclus
antibodi
medium
overlay
dilut
complet
restrict
replic
effect
contrast
previous
show
partial
sensit
antibodi
vitro
evalu
replic
vivo
infect
group
guinea
pig
rout
dose
pfu
day
post
infect
anim
euthan
lung
isol
homogen
viru
titer
determin
fig
interestingli
viru
detect
anim
infect
wherea
readili
recover
although
titer
latter
viru
reduc
log
compar
day
peak
viru
replic
fig
sinc
detect
plaqu
titrat
lung
homogen
attempt
detect
evid
infect
immunohistochem
analysi
organ
isol
infect
anim
guinea
pig
infect
rout
dose
pfu
day
infect
anim
euthan
lung
organ
list
isol
fix
formalin
embed
paraffin
tissu
section
prepar
stain
rabbit
serum
purifi
virion
react
variou
protein
includ
intern
protein
data
shown
thu
would
detect
intern
protein
anim
infect
viral
antigen
detect
bronchi
larg
bronchiol
extend
inflammatori
alveolar
lesion
moder
amount
antigen
bronchi
less
smaller
airway
fig
c
also
observ
previou
studi
yang
et
al
viral
antigen
detect
variou
part
lung
number
cell
involv
low
fig
show
exampl
lung
tissu
section
posit
viral
antigen
one
focu
posit
stain
present
alveoli
adjac
bronchu
neg
addit
examin
kidney
liver
thymu
salivari
gland
mediastin
mesenter
poplit
lymph
node
reveal
histopatholog
chang
antigen
three
virus
data
shown
taken
togeth
data
confirm
pneumotrop
suggest
highli
attenu
vivo
detect
dissemin
beyond
respiratori
tract
evalu
immunogen
comparison
ebogp
protect
efficaci
previous
demonstr
guinea
pig
monkey
bukreyev
et
al
group
guinea
pig
immun
rout
dose
pfu
fig
group
dose
pfu
group
dose
pfu
group
intramuscular
im
rout
dose
pfu
group
addit
group
immun
pfu
includ
alreadi
note
pfu
dose
viru
convert
tcid
lower
equal
pfu
dose
evalu
possibl
respons
due
preform
antigen
viru
inoculum
inactiv
uv
irradi
addit
group
anim
immun
im
rout
group
equival
pfu
serum
sampl
collect
day
immun
test
ebovspecif
antibodi
elisa
inactiv
virion
fig
panel
ebov
neutral
assay
panel
b
antibodi
hai
panel
c
regard
ebovspecif
serum
elisa
titer
fig
panel
administr
rout
dose
pfu
induc
titer
respect
day
fig
group
respect
day
antibodi
level
increas
respect
level
fold
lower
induc
experi
day
respect
group
despit
highli
restrict
replic
ebogp
compar
inocul
uvinactiv
ebogp
control
group
induc
littl
respons
confirm
replic
detect
base
viru
titrat
lung
homogen
fig
immunogen
viru
depend
genom
replic
im
immun
group
induc
titer
day
respect
thu
substanti
less
immunogen
rout
howev
separ
experi
shown
im
immun
induc
greater
p
level
serum
elisa
antibodi
im
immun
ebogp
im
immun
uvinactiv
control
group
result
low
level
respons
regard
ebovneutr
serum
antibodi
titer
fig
respons
detect
anim
immun
rout
dose
group
anim
immun
rout
dose
anim
immun
im
rout
group
mean
antibodi
titer
group
parallel
detect
elisa
lack
detect
serum
ebovneutr
antibodi
seen
anim
necessarili
correl
lack
protect
evalu
neutral
titer
previou
studi
guinea
pig
rhesu
monkey
bukreyev
et
al
studi
vesicular
stomat
virusvector
ebov
gp
cynomolgu
macaqu
document
complet
protect
ebov
challeng
everi
anim
even
though
neutral
serum
antibodi
undetect
anim
follow
vaccin
jone
et
al
regard
hai
serum
antibodi
fig
respons
detect
group
immun
group
would
expect
given
lack
hn
protein
separ
experi
also
evalu
whether
prior
infect
would
reduc
immunogen
question
also
recent
investig
yang
et
al
might
occur
exampl
intern
protein
common
induc
signific
protect
immun
effect
latter
viru
also
test
lower
dose
vaccin
order
compar
respons
immun
greater
dose
use
previou
experi
guinea
pig
mockinfect
anim
infect
anim
pfu
fortynin
day
later
serum
sampl
collect
analyz
hai
antibodi
anim
infect
pfu
tabl
twenti
eight
day
later
serum
sampl
taken
analyz
ebovspecif
elisa
serum
antibodi
mean
log
titer
ebovspecif
antibodi
slightli
less
reduc
group
compar
anim
statist
signific
differ
two
group
either
time
point
similar
result
recent
describ
ebogp
yang
et
al
evalu
protect
efficaci
group
guinea
pig
infect
rout
pfu
pfu
pfu
day
post
immun
anim
challeng
otherwis
uniformli
lethal
pfu
dose
guinea
pigadapt
ebovzair
connolli
et
al
ip
rout
ld
pfu
ratio
clone
ebov
unknown
note
valu
determin
five
guinea
pigadapt
strain
ebov
administ
ip
rout
volchkov
et
al
suggest
case
ip
challeng
dose
probabl
exceed
ld
follow
challeng
clinic
observ
weigh
anim
perform
daili
fig
challeng
result
weight
loss
control
anim
start
day
follow
appear
clinic
sign
ebov
infect
start
day
clinic
score
describ
legend
fig
control
anim
die
day
one
remain
anim
euthan
day
accord
approv
anim
use
protocol
due
sever
diseas
contrast
anim
immun
show
diseas
sign
immun
anim
surviv
separ
experi
guinea
pig
immun
rout
pfu
pfu
four
anim
per
group
day
immun
anim
challeng
ip
pfu
guinea
pigadapt
ebov
describ
day
follow
challeng
anim
euthan
blood
spleen
liver
lung
sampl
collect
analyz
ebov
titrat
control
anim
high
level
infecti
ebov
detect
tissu
mean
se
blood
log
tcid
ml
spleen
log
tcid
g
liver
log
tcid
g
lung
log
tcid
g
contrast
viru
detect
tissu
anim
thu
immun
confer
solid
protect
ip
challeng
uniformli
lethal
dose
ebov
replac
hn
f
protein
recombin
wild
type
gp
ebov
result
viabl
chimer
viru
ebov
gp
sole
surfac
glycoprotein
interestingli
retain
gener
size
shape
particl
envelop
thick
spike
morpholog
resembl
ebov
particl
even
though
ebov
differ
viru
famili
lack
related
hn
f
protein
versu
gp
chimer
viru
replic
vero
monkey
kidney
cell
titer
similar
effici
growth
vero
cell
particularli
import
sinc
provid
accept
substrat
vaccin
manufactur
initi
anticip
ebov
gp
might
effici
incorpor
particl
might
function
foreign
envelop
therefor
also
construct
parallel
version
call
ct
ebov
gp
replac
f
protein
done
address
possibl
compat
ct
gp
intern
protein
particl
might
import
effici
product
infecti
particl
previous
observ
studi
hn
f
glycoprotein
replac
tao
et
al
howev
present
studi
modif
reduc
rather
increas
effici
product
infecti
viru
pursu
may
ebov
gp
f
protein
significantli
relat
chimer
protein
creat
two
might
fold
correctli
might
function
suboptim
polar
viral
bud
polar
epitheli
cell
greatli
affect
pathogen
viru
exampl
sendai
viru
mutat
confer
abil
bud
basolater
surfac
respiratori
epithelium
contribut
system
diseas
associ
wild
type
viru
bud
apic
surfac
tashiro
et
al
caus
highli
local
infect
respiratori
airway
replic
primarili
apic
cell
lumin
surfac
respiratori
epithelium
phenotyp
recapitul
infect
hae
vitro
shown
previou
work
zhang
et
al
contrast
marburg
viru
close
relat
filoviru
releas
basolater
membran
infect
polar
epitheli
cell
even
though
gp
protein
express
alon
context
viral
infect
predomin
transport
apic
surfac
sanger
et
al
presenc
ebov
gp
sole
surfac
protein
thu
potenti
chang
bud
phenotyp
tissu
tropism
vector
possibl
investig
use
well
character
vitro
model
polar
mucocilliari
hae
pickl
et
al
presenc
ebov
gp
appear
confer
abil
infect
cell
basolater
surfac
appli
directli
surfac
albeit
ineffici
wherea
detect
infect
basolater
surfac
howev
express
ebov
gp
confer
abil
spread
infect
apic
cell
underli
cell
whether
hae
infect
apic
basolater
surfac
viru
releas
basolater
surfac
appear
insignific
addit
guinea
pig
inocul
rout
presenc
ebov
gp
result
detect
system
infect
matrix
protein
marburg
viru
recent
found
contribut
basolater
bud
viru
retarget
gp
protein
apic
basolater
membran
kolesnikova
et
al
backbon
lack
ebov
interact
would
lack
presum
supplement
intern
protein
inde
ebov
gp
accumul
primarili
apic
surfac
hae
consist
previou
report
marburg
viru
sanger
et
al
interestingli
accumul
gp
local
cilia
although
replic
high
titer
vero
cell
highli
attenu
vivo
high
level
immunogen
hpiv
fhn
despit
poor
replic
compar
might
due
least
part
format
gp
spike
surfac
fhnebogp
particl
fig
exampl
case
hemagglutinin
avian
influenza
viru
trimer
form
virion
spike
immunogen
monom
multimer
spike
immunogen
form
wei
et
al
similarli
abund
display
gp
spike
fhnebogp
particl
compar
ineffici
incorpor
particl
might
provid
greater
immunogen
recent
candid
vaccin
viru
ebov
describ
base
recombin
vesicular
stomat
viru
vsv
vsv
surfac
glycoprotein
g
replac
gp
ebov
garbutt
et
al
vaccin
viru
replic
less
effici
vsv
parent
vitro
although
given
high
effici
replic
inher
parent
vsv
backbon
vaccin
manufactur
would
still
feasibl
singl
im
inocul
cynomolgu
macaqu
pfu
vsvbase
chimera
result
transient
viremia
anim
base
viru
isol
induc
detect
neutral
serum
antibodi
anim
becam
detect
challeng
confer
complet
protect
anim
im
challeng
pfu
ebov
jone
et
al
appear
substanti
attenu
vsvbase
construct
base
lack
recover
vaccin
viru
guinea
pig
experiment
anim
permiss
ebov
despit
high
degre
attenu
singl
dose
pfu
induc
ebovneutr
serum
antibodi
anim
respect
complet
protect
ip
ebov
challeng
alreadi
note
im
immun
pfu
induc
ebovneutr
serum
antibodi
anim
indic
vaccin
substanti
immunogen
rout
import
extend
evalu
nonhuman
primat
candid
vaccin
ebov
sever
advantag
predecessor
express
hn
f
addit
ebov
gp
surfac
protein
first
nearli
greater
incorpor
gp
particl
compar
presum
due
lack
competit
hn
f
packag
absenc
hn
f
compet
antigen
presenc
gp
order
spike
resembl
filoviru
particl
also
might
provid
increas
immunogen
second
lack
hn
f
neutral
antigen
resist
preexist
immun
previous
found
guinea
pig
immun
prior
infect
complet
block
replic
subsequ
dose
ebogp
yang
et
al
interestingli
previou
studi
gp
retain
much
immunogen
despit
lack
detect
replic
vector
yang
et
al
note
immunogen
nonhuman
primat
human
remain
determin
thu
provid
altern
preexist
immun
vector
problem
third
highli
attenu
alreadi
note
thu
safe
taken
togeth
data
provid
strong
case
pursu
parallel
vaccin
candid
respiratori
immun
ebov
warrant
test
nonhuman
primat
design
express
complet
ebov
gp
ebov
gp
bear
cytoplasm
tail
ct
respect
sole
viral
surfac
protein
fig
construct
previouslydescrib
fulllength
cdna
encod
consist
complet
backbon
transcript
cassett
contain
orf
ebov
gp
flank
genestart
gs
geneend
ge
transcript
signal
insert
p
gene
fig
f
hn
gene
delet
follow
fig
first
construct
modifi
insert
stui
site
downstream
noncod
region
hn
gene
open
read
frame
orf
geneend
transcript
signal
fig
done
replac
xhoi
sphi
fragment
cdna
site
uniqu
locat
posit
respect
correspond
fragment
previouslyconstruct
plasmid
durbin
et
al
contain
fulllength
cdna
three
point
mutat
introduc
creat
abovement
stui
site
durbin
et
al
replac
result
plasmid
next
use
pcr
amplifi
modifi
nucleotid
cdna
segment
span
orf
introduc
stui
site
three
nucleotid
downstream
orf
done
use
forward
primer
atttcttgctgcagcgatgg
posit
revers
primer
gataggcctttactagttccattgtttga
underlin
sequenc
primer
complementari
downstream
end
orf
stui
site
bold
pcr
product
digest
endogen
site
present
nucleotid
gp
gene
stui
clone
pflmistui
window
ebogpstui
delet
f
hn
gene
creat
fulllength
ebogp
cdna
construct
cdna
encod
cytoplasm
tail
ct
gp
protein
replac
f
fig
perform
follow
clone
vector
promega
inc
madison
wi
modifi
remov
restrict
site
replac
speinsii
fragment
contain
two
site
irrelev
speinsii
fragment
lack
site
result
plasmid
next
ncoincoi
fragment
posit
includ
downstream
end
ebov
gp
gene
clone
uniqu
ncoi
site
plasmid
result
plasmid
amplifi
code
sequenc
f
gene
ct
pcr
use
primer
ad
ebov
sequenc
clone
site
either
end
forward
primer
gacaatggataccggcaggtattggagttacaggcgttgtaattgcagttatc
gctttattctgtatatgcaagtattacagaattcaaaa
underlin
sequenc
encod
upstream
end
f
ct
remaind
encod
tm
ebov
gp
naturallyoccur
bfuai
recognit
sequenc
italic
revers
primer
tcttaaacgcgtattatttgtttgttagtacat
underlin
sequenc
complementari
encod
downstream
end
f
ct
remaind
downstream
noncod
sequenc
ebov
gp
transcript
cassett
mlui
site
latter
sequenc
bold
pcr
product
digest
mlui
bfuai
fragment
use
replac
correspond
mluibfuai
fragment
ebov
gp
segment
plasmid
replac
ct
ebov
gp
f
result
plasmid
final
ncoincoi
fragment
plasmidborn
segment
use
replac
correspond
ncoincoi
fragment
result
cdna
encod
modif
cdna
confirm
sequenc
analysi
recombin
virus
recov
cell
cultur
use
previouslydescrib
method
recombin
ebogp
viru
amplifi
three
passag
cell
stock
prepar
rhesu
monkey
kidney
cell
american
type
cultur
collect
manassa
va
optimem
medium
invitrogen
carlsbad
ca
contain
fetal
bovin
serum
invitrogen
plaqu
titrat
perform
previous
describ
case
tcid
tissu
cultur
infecti
dose
titer
determin
limit
dilut
cell
sensit
virus
rabbit
antibodi
evalu
use
guinea
pig
complement
cambrex
corpor
east
rutherford
nj
describ
result
growth
kinet
virus
determin
cell
african
green
monkey
kidney
vero
cell
human
type
ii
alveolar
adenocarcinoma
cell
american
type
cultur
collect
grown
optimem
medium
contain
fetal
bovin
serum
invitrogen
comparison
plaqu
morpholog
plaqu
immunostain
serum
plaqu
immunostain
parallel
dilut
rabbit
antiserum
prepar
ebov
inactiv
gamma
irradi
kindli
provid
dr
sanchez
center
control
prevent
atlanta
ga
purifi
centrifug
sucros
step
gradient
describ
previous
purifi
viral
particl
bound
formvarcarbonco
nickel
grid
electron
microscopi
scienc
hatfield
pa
neg
stain
ammonium
molybd
grid
examin
use
model
transmiss
electron
microscop
hitachi
high
technolog
schaumburg
il
kv
imag
obtain
digit
camera
system
advanc
microscopi
techniqu
danver
sucros
gradientpurifi
viru
prepar
subject
polyacrylamid
gel
electrophoresi
reduc
denatur
condit
use
gradient
nupag
gel
invitrogen
silver
stain
done
use
silverquest
kit
invitrogen
accord
manufactur
recommend
western
blot
perform
convent
method
use
guinea
pig
antiserum
rais
immun
dna
vector
express
ebov
gp
gener
provid
sanchez
center
diseas
control
prevent
atlanta
ga
tracheobronchi
epitheli
cell
obtain
clinic
specimen
univers
north
carolina
chapel
hill
cystic
fibrosi
center
tissu
cultur
core
unc
institut
review
boardapprov
protocol
primari
cell
expand
one
passag
vitrogenco
plastic
dish
plate
cell
per
mm
millicel
cultur
insert
pore
size
millipor
allow
differenti
airliquid
interfac
week
previous
describ
zhang
et
al
apic
inocul
pfu
viral
suspens
input
moi
pfucel
appli
apic
surfac
hae
cultur
incub
h
inoculum
remov
apic
surfac
wash
twice
ml
phosphat
buffer
salin
cultur
return
basolater
inocul
hae
insert
invert
inocul
h
basolater
surfac
wash
one
time
ml
phosphat
buffer
salin
insert
return
origin
orient
determin
growth
kinet
virus
aliquot
fresh
medium
ad
apic
surfac
specif
time
point
incub
min
harvest
apic
wash
basolater
supernat
also
harvest
replac
fresh
medium
aliquot
frozen
plaqu
titrat
cell
identif
cell
type
infect
virus
hae
fix
paraformaldehyd
paraffin
embed
cut
section
viral
antigen
detect
rabbit
antiserum
purifi
ebov
virion
describ
red
conjug
goat
antirabbit
secondari
antibodi
invitrogen
nuclei
counterstain
hoechst
dye
invitrogen
fluoresc
confoc
imag
well
optic
differenti
interfer
contrast
dic
imag
obtain
use
leica
aob
upright
laser
scan
confoc
microscop
overlaid
imag
construct
use
adob
photoshop
softwar
adob
system
inc
san
jose
ca
guinea
pig
strain
hartley
charl
river
laboratori
wilmington
confirm
seroneg
hemagglutinin
inhibit
hai
assay
use
guinea
pig
erythrocyt
inocul
perform
appli
viru
suspens
medium
invitrogen
nostril
mild
anesthesia
methoxyfluran
medic
develop
intern
limit
springval
australia
intramuscular
im
inocul
viral
suspens
inject
gastrocnemiu
muscl
light
anesthesia
procedur
guinea
pig
perform
accord
protocol
guidelin
approv
nih
anim
care
use
committe
perform
facil
approv
associ
assess
accredit
laboratori
anim
care
intern
immunohistochem
analysi
anim
tissu
perform
describ
previous
yang
et
al
use
rabbit
serum
purifi
virion
stain
plaqu
almost
effici
plaqu
due
reactiv
surfac
intern
protein
data
shown
ebovspecif
enzymelink
immunosorb
assay
elisa
perform
previous
describ
yang
et
al
use
purifi
ebov
particl
inactiv
gammairradi
kindli
provid
dr
sanchez
center
diseas
control
prevent
atlanta
ga
antigen
ebov
neutral
antibodi
titer
determin
previous
describ
jahrl
jone
et
al
except
endpoint
plaqu
reduct
rather
antibodi
titer
determin
hemagglutin
inhibit
assay
hai
describ
previous
van
wyke
coelingh
winter
murphi
experi
involv
challeng
ebov
perform
biosafeti
level
facil
canadian
nation
microbiolog
laboratori
experi
approv
anim
care
committe
canadian
scienc
centr
human
anim
health
winnipeg
canada
follow
guidelin
canadian
council
anim
care
ottawa
canada
guinea
pig
adapt
ebov
speci
zair
produc
serial
passag
anim
uniformli
lethal
connolli
et
al
administ
ip
rout
dose
pfu
follow
challeng
anim
weigh
daili
diseas
evalu
use
score
system
describ
legend
fig
analysi
ebov
blood
intern
organ
perform
previous
describ
jone
et
al
mean
ebov
titer
blood
spleen
liver
determin
base
one
sampl
per
anim
four
anim
group
viral
titer
lung
determin
base
one
sampl
lung
ie
two
sampl
per
anim
four
anim
per
group
control
group
ebov
detect
right
lung
one
anim
purpos
calcul
titer
twofold
limit
detect
assign
neg
sampl
differ
evalu
student
ttest
consid
signific
p
data
shown
mean
se
mean
construct
express
complet
ebov
gp
express
ebov
gp
bear
cytoplasm
tail
ct
f
protein
genom
map
descend
order
complet
infecti
previous
deriv
bukreyev
et
al
insert
p
gene
transcript
cassett
express
complet
ebov
gp
deriv
delet
f
hn
gene
deriv
replac
ct
ebov
gp
f
genom
nucleotid
length
shown
left
b
delet
f
hn
gene
region
genom
span
f
hn
l
gene
shown
orf
indic
fill
rectangl
flank
horizont
line
indic
noncod
gene
region
gene
junction
indic
fill
bar
denot
geneend
ge
signal
short
horizont
line
denot
intergen
ig
trinucleotid
fill
arrowhead
denot
genestart
gs
signal
sequenc
delet
point
expand
diagram
stui
site
introduc
nucleotid
upstream
hn
ge
signal
italic
delet
begin
fourth
nucleotid
follow
orf
end
abovement
stui
site
c
replac
ct
ebov
gp
f
top
downstream
part
ebov
gp
shown
transmembran
domain
tm
ct
indic
dash
solid
line
respect
bottom
modifi
chimer
gp
gp
ct
replac
much
longer
ct
f
stop
codon
depict
asterisk
bfuai
mlui
recognit
sequenc
present
ebov
gp
transcript
cassett
use
replac
italic
cleavag
site
indic
arrowhead
note
bfuai
cut
outsid
case
upstream
recognit
sequenc
electron
micrograph
negativestain
particl
ebov
note
envelop
thinner
contain
spike
resembl
ebov
rather
convers
shape
particl
resembl
rather
ebov
ebov
imag
kindli
provid
c
humphrey
sanchez
center
diseas
control
prevent
atlanta
ga
analysi
purifi
virion
gel
electrophoresi
conjunct
silver
stain
western
blot
use
guinea
pig
antiserum
rais
dna
vaccin
express
ebov
gp
b
lane
magicmark
xp
invitrogen
correspond
molecular
weight
indic
left
p
hn
n
band
identifi
base
publish
profil
storey
dimock
kang
wechsler
et
al
posit
ebov
gp
indic
replic
cell
monolay
plaqu
format
cell
cell
incub
methycellulos
day
fix
analyz
immunostain
rabbit
antiserum
rrais
purifi
virion
panel
purifi
inactiv
ebov
virion
panel
b
growth
kinet
ebogp
vero
cell
cell
infect
moi
pfucel
adsorpt
period
wash
three
time
incub
aliquot
overli
medium
taken
day
replac
fresh
medium
viral
titer
aliquot
determin
plaqu
titrat
cell
mean
valu
se
base
three
monolay
per
viru
shown
limit
detect
log
pfuml
except
day
log
pfuml
note
mani
time
point
error
bar
seen
due
low
variabl
cell
infect
monolay
complet
destroy
day
therefor
medium
aliquot
collect
data
one
two
independ
experi
perform
shown
growth
kinet
infect
vitro
model
human
airway
epithelium
hae
row
b
row
c
row
e
select
repres
crosssect
imag
hae
inocul
either
apic
left
column
basolater
surfac
right
column
note
method
use
basolater
inocul
expos
surfac
infect
see
text
fix
analyz
immunostain
day
day
viral
antigen
detect
rabbit
antiserum
rais
purifi
virion
row
b
c
purifi
inactiv
ebov
virion
row
e
first
antibodi
follow
label
second
antibodi
red
nuclei
stain
blue
dapi
treatment
growth
kinet
hae
triplic
hae
cultur
inocul
virus
moi
pfu
via
apic
basolater
apic
surfac
viral
supernat
apic
basolater
compart
harvest
viral
titer
determin
plaqu
titrat
cell
mean
repres
three
sampl
per
group
se
sampl
limit
detect
log
pfuml
valu
twofold
limit
log
pfuml
assign
calcul
mean
immunohistochem
analysi
viral
antigen
distribut
guinea
pig
lung
day
infect
pfu
c
e
f
mock
infect
b
c
viral
antigen
detect
bronchial
epithelium
f
focu
posit
stain
present
alveoli
adjac
bronchiol
neg
e
lack
viral
antigen
bronchu
viral
antigen
stain
brown
background
hematoxylin
counterstain
cell
posit
antigen
shown
green
arrow
challeng
ebov
guinea
pig
immun
pfu
anim
pfu
anim
pfu
anim
challeng
day
later
pfu
ebov
ip
rout
percent
chang
bodi
weight
follow
ebov
challeng
daili
mean
weight
se
shown
express
percentag
weight
day
one
anim
group
die
se
calcul
base
remain
live
anim
minimum
anim
per
group
b
kaplanmai
surviv
curv
clinic
diseas
score
anim
immun
surviv
control
anim
die
diseas
sign
observ
control
group
score
daili
four
anim
follow
ruffl
fur
reduc
activ
loss
bodi
condit
labor
breath
hunch
postur
bleed
mark
lethargi
extrem
sever
row
repres
daili
score
one
four
control
anim
group
end
vertic
line
day
death
one
anim
shown
bottom
euthan
day
due
sever
diseas
